Adma Biologics IncのSMA 200
Adma Biologics IncのSMA 200は何ですか。
Adma Biologics IncのSMA 200は$10 +42.12%です。
SMA 200の定義は何ですか。
SMA 200は、過去200日間の終値の非加重平均として計算された過去200日間の平均株価です。
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NASDAQのセクタHealth CareにおけるSMA 200の企業と比べるAdma Biologics Inc
Adma Biologics Incは何をしますか。
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Adma Biologics Incと類似のsma 200
- Canopy GrowthのSMA 200はCAD$10 -52.08%です。
- Eaton Vance New York Municipal Bond FundのSMA 200は$10 +1.91%です。
- Eaton Vance Duration Income FundのSMA 200は$10 +5.51%です。
- Herbalife LtdのSMA 200は$10 -35.66%です。
- The Bank of East AsiaのSMA 200はHKD$10 -4.84%です。
- Invesco Municipal Opportunity TrustのSMA 200は$10 +4.98%です。
- Adma Biologics IncのSMA 200は$10 +42.12%です。
- RepayのSMA 200は$10 -24.55%です。
- Curis IncのSMA 200は$10 -92.01%です。
- Multiconsult AsaのSMA 200は$10 -Inf%です。
- ReposiTrakのSMA 200は$10 +0.00%です。
- Tailwind AcquisitionのSMA 200は$10 +0.00%です。
- Safestore plcのSMA 200は$10 +14.07%です。